| [1] |
Kurz H, Göpfrich H, Wabnegger L, et al. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria [J]. Pediatr Pulmonol, 2009, 44(9): 873-876. DOI: 10.1002/ppul.21059.
|
| [2] |
|
| [3] |
Li X, Ma J, Li Y, et al. One-year epidemiological patterns of respiratory pathogens across age, gender, and seasons in Chengdu during the post-COVID era [J]. Sci Rep, 2025, 15(1): 357. DOI: 10.1038/s41598-024-84586-8.
|
| [4] |
Brouard J, Freymuth F, Toutain F, et al. Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children [J]. Arch Pediatr, 2002, 9(Suppl 3): 365s-371s. DOI: 10.1016/s0929-693x(02)00145-8.
|
| [5] |
Tagini F, Opota O, Greub G. Chlamydia pneumoniae upsurge at tertiary hospital, Lausanne, Switzerland [J]. Emerg Infect Dis, 2024, 30(4): 810-812. DOI: 10.3201/eid3004.231610.
|
| [6] |
Han HY, Moon JU, Rhim JW, et al. Surge of Chlamydia pneumoniae pneumonia in children hospitalized with community-acquired pneumonia at a single center in Korea in 2016 [J]. J Infect Chemother, 2023, 29(5): 453-457. DOI: 10.1016/j.jiac.2023.01.012.
|
| [7] |
Tian Q, Xin-Cheng Q, Yamin S, et al. Surge in Chlamydia pneumoniae infections in China: insights from 2022 to 2024 [J]. Emerg Microbes Infect, 2025, 14(1): 2552719. DOI: 10.1080/22221751.2025.2552719.
|
| [8] |
Huang Y, Chen Y, Liu M, et al. Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP [J]. BMC Infect Dis, 2025, 25(1): 993. DOI: 10.1186/s12879-025-11405-4.
|
| [9] |
De Francesco MA, Poiesi C, Gargiulo F, et al. Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features [J]. J Infect, 2021, 82(4): e4-e7. DOI: 10.1016/j.jinf.2021.01.009.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
Di Pietro M, Filardo S, Romano S, et al. Chlamydia trachomatis and Chlamydia pneumoniae interaction with the host: latest advances and future prospective [J]. Microorganisms, 2019, 7(5): 140. DOI: 10.3390/microorganisms7050140.
|
| [14] |
Edouard S, Attamna R, Million M, et al. Significant rise of Chlamydia pneumoniae infection in 2024 in Marseille, France [J]. Int J Infect Dis, 2025, 155: 107897. DOI: 10.1016/j.ijid.2025.107897.
|
| [15] |
|
| [16] |
Boutin S, Krumbholz A, Kramer TS, et al. Sharp increase in Chlamydia pneumoniae infections in 2024 in Germany [J]. Eur J Clin Microbiol Infect Dis, 2025. DOI: 10.1007/s10096-025-05244-z. [Epub ahead of print]
|
| [17] |
Vieyra JM, De Colsa Ranero A, Reyes DP, et al. Chlamydophila pneumoniae-associated community-acquired pneumonia in paediatric patients of a tertiary care hospital in Mexico: molecular diagnostic and clinical insights [J]. Sci Rep, 2023, 13(1): 21477. DOI: 10.1038/s41598-023-48701-5.
|
| [18] |
Thom DH, Grayston JT. Infections with Chlamydia pneumoniae strain TWAR [J]. Clin Chest Med, 1991, 12(2): 245-256.
|
| [19] |
Almirall J, Morató I, Riera F, et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study [J]. Eur Respir J, 1993, 6(1): 14-18.
|
| [20] |
|